STRATA Skin Sciences closes $2.42 million registered direct offering

STRATA Skin Sciences Inc. (NASDAQ: SSKN) completed a registered direct offering on September 4, raising approximately $2.42 million in gross proceeds before fees and expenses.

The medical technology company sold 1,097,547 shares of common stock at $2.204 per share. Ladenburg Thalmann & Co. Inc. served as the exclusive placement agent for the transaction.

The company plans to use the net proceeds for working capital and general corporate purposes, according to the press release statement.

The securities were offered through a shelf registration statement on Form S-3 that the Securities and Exchange Commission declared effective on December 18, 2024. A prospectus supplement was filed with the SEC on September 3, 2025.

STRATA Skin Sciences develops and markets medical devices for treating dermatologic conditions including psoriasis, vitiligo, and acne. The company's products include the XTRAC excimer laser, VTRAC lamp systems, and TheraClear X Acne Therapy System.

You May Also Be Interested In

• Amtech Systems closes $60 million public stock offering
• TransAlta buys Colorado gas plants for US$1 billion, raises $350 million
• Aeva Technologies files mixed shelf offering registration